vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and Dole plc (DOLE). Click either name above to swap in a different company.

Dole plc is the larger business by last-quarter revenue ($2.3B vs $1.2B, roughly 1.8× Alignment Healthcare, Inc.). Alignment Healthcare, Inc. runs the higher net margin — 0.9% vs 0.2%, a 0.7% gap on every dollar of revenue. On growth, Dole plc posted the faster year-over-year revenue change (10.5% vs -74.7%). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (34.6% CAGR vs 3.2%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

Dole plc is an Irish-American agricultural multinational corporation headquartered in Dublin, Ireland. The company is among the world's largest producers of fruit and vegetables, operating with 38,500 full-time and seasonal employees who supply some 300 products in 75 countries. Dole reported 2021 revenues of $6.5 billion.

ALHC vs DOLE — Head-to-Head

Bigger by revenue
DOLE
DOLE
1.8× larger
DOLE
$2.3B
$1.2B
ALHC
Growing faster (revenue YoY)
DOLE
DOLE
+85.2% gap
DOLE
10.5%
-74.7%
ALHC
Higher net margin
ALHC
ALHC
0.7% more per $
ALHC
0.9%
0.2%
DOLE
Faster 2-yr revenue CAGR
ALHC
ALHC
Annualised
ALHC
34.6%
3.2%
DOLE

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
ALHC
ALHC
DOLE
DOLE
Revenue
$1.2B
$2.3B
Net Profit
$11.4M
$5.1M
Gross Margin
6.8%
Operating Margin
1.1%
Net Margin
0.9%
0.2%
Revenue YoY
-74.7%
10.5%
Net Profit YoY
-64.6%
EPS (diluted)
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
DOLE
DOLE
Q1 26
$1.2B
Q4 25
$1.0B
Q3 25
$993.7M
$2.3B
Q2 25
$1.0B
$2.4B
Q1 25
$926.9M
$2.1B
Q4 24
$701.2M
Q3 24
$692.4M
$2.1B
Q2 24
$681.3M
$2.1B
Net Profit
ALHC
ALHC
DOLE
DOLE
Q1 26
$11.4M
Q4 25
$-11.0M
Q3 25
$3.7M
$5.1M
Q2 25
$15.7M
$10.0M
Q1 25
$-9.1M
$38.9M
Q4 24
$-31.1M
Q3 24
$-26.4M
$14.4M
Q2 24
$-24.0M
$80.1M
Gross Margin
ALHC
ALHC
DOLE
DOLE
Q1 26
Q4 25
Q3 25
6.8%
Q2 25
9.0%
Q1 25
8.7%
Q4 24
Q3 24
8.0%
Q2 24
9.4%
Operating Margin
ALHC
ALHC
DOLE
DOLE
Q1 26
Q4 25
-1.0%
Q3 25
0.8%
1.1%
Q2 25
2.2%
4.3%
Q1 25
-0.6%
3.2%
Q4 24
-3.2%
Q3 24
-2.8%
2.3%
Q2 24
-2.7%
4.0%
Net Margin
ALHC
ALHC
DOLE
DOLE
Q1 26
0.9%
Q4 25
-1.1%
Q3 25
0.4%
0.2%
Q2 25
1.5%
0.4%
Q1 25
-1.0%
1.9%
Q4 24
-4.4%
Q3 24
-3.8%
0.7%
Q2 24
-3.5%
3.8%
EPS (diluted)
ALHC
ALHC
DOLE
DOLE
Q1 26
Q4 25
$-0.04
Q3 25
$0.02
$0.05
Q2 25
$0.07
$0.10
Q1 25
$-0.05
$0.41
Q4 24
$-0.15
Q3 24
$-0.14
$0.15
Q2 24
$-0.13
$0.84

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
DOLE
DOLE
Cash + ST InvestmentsLiquidity on hand
$705.6M
$321.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$206.9M
$1.4B
Total Assets
$1.3B
$4.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
DOLE
DOLE
Q1 26
$705.6M
Q4 25
$604.2M
Q3 25
$644.1M
$321.0M
Q2 25
$503.8M
$323.1M
Q1 25
$479.5M
$261.0M
Q4 24
$470.6M
Q3 24
$381.0M
$266.4M
Q2 24
$363.7M
$225.8M
Total Debt
ALHC
ALHC
DOLE
DOLE
Q1 26
Q4 25
$323.2M
Q3 25
$322.7M
Q2 25
$322.3M
Q1 25
$321.9M
Q4 24
$321.4M
Q3 24
$212.0M
Q2 24
$211.7M
Stockholders' Equity
ALHC
ALHC
DOLE
DOLE
Q1 26
$206.9M
Q4 25
$179.3M
Q3 25
$161.9M
$1.4B
Q2 25
$141.0M
$1.4B
Q1 25
$108.1M
$1.3B
Q4 24
$99.9M
Q3 24
$114.5M
$1.4B
Q2 24
$123.7M
$1.4B
Total Assets
ALHC
ALHC
DOLE
DOLE
Q1 26
$1.3B
Q4 25
$1.1B
Q3 25
$1.1B
$4.5B
Q2 25
$1.0B
$4.7B
Q1 25
$895.6M
$4.5B
Q4 24
$782.1M
Q3 24
$692.3M
$4.5B
Q2 24
$716.3M
$4.4B
Debt / Equity
ALHC
ALHC
DOLE
DOLE
Q1 26
Q4 25
1.80×
Q3 25
1.99×
Q2 25
2.29×
Q1 25
2.98×
Q4 24
3.22×
Q3 24
1.85×
Q2 24
1.71×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
DOLE
DOLE
Operating Cash FlowLast quarter
$128.7M
$87.4M
Free Cash FlowOCF − Capex
$66.5M
FCF MarginFCF / Revenue
2.9%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
11.27×
17.12×
TTM Free Cash FlowTrailing 4 quarters
$13.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
DOLE
DOLE
Q1 26
$128.7M
Q4 25
$-50.4M
Q3 25
$144.6M
$87.4M
Q2 25
$29.1M
$18.3M
Q1 25
$16.6M
$-78.8M
Q4 24
$-8.7M
Q3 24
$26.2M
$101.0M
Q2 24
$23.5M
$40.2M
Free Cash Flow
ALHC
ALHC
DOLE
DOLE
Q1 26
Q4 25
$-55.4M
Q3 25
$139.1M
$66.5M
Q2 25
$21.1M
$-1.0M
Q1 25
$8.4M
$-131.6M
Q4 24
$-18.0M
Q3 24
$16.9M
$79.9M
Q2 24
$11.8M
$22.8M
FCF Margin
ALHC
ALHC
DOLE
DOLE
Q1 26
Q4 25
-5.5%
Q3 25
14.0%
2.9%
Q2 25
2.1%
-0.0%
Q1 25
0.9%
-6.3%
Q4 24
-2.6%
Q3 24
2.4%
3.9%
Q2 24
1.7%
1.1%
Capex Intensity
ALHC
ALHC
DOLE
DOLE
Q1 26
Q4 25
0.5%
Q3 25
0.6%
0.9%
Q2 25
0.8%
0.8%
Q1 25
0.9%
2.5%
Q4 24
1.3%
Q3 24
1.3%
1.0%
Q2 24
1.7%
0.8%
Cash Conversion
ALHC
ALHC
DOLE
DOLE
Q1 26
11.27×
Q4 25
Q3 25
38.77×
17.12×
Q2 25
1.86×
1.84×
Q1 25
-2.02×
Q4 24
Q3 24
7.01×
Q2 24
0.50×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons